Logo image of REAX

REAL BROKERAGE INC/THE (REAX) Stock Fundamental Analysis

NASDAQ:REAX - Nasdaq - CA75585H2063 - Common Stock - Currency: USD

4.66  +0.22 (+4.95%)

After market: 4.5 -0.16 (-3.43%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to REAX. REAX was compared to 64 industry peers in the Real Estate Management & Development industry. While REAX has a great health rating, there are worries on its profitability. REAX is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year REAX has reported negative net income.
REAX had a positive operating cash flow in the past year.
REAX had negative earnings in each of the past 5 years.
Of the past 5 years REAX 4 years had a positive operating cash flow.
REAX Yearly Net Income VS EBIT VS OCF VS FCFREAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

REAX's Return On Assets of -30.65% is on the low side compared to the rest of the industry. REAX is outperformed by 82.81% of its industry peers.
REAX's Return On Equity of -82.56% is on the low side compared to the rest of the industry. REAX is outperformed by 76.56% of its industry peers.
Industry RankSector Rank
ROA -30.65%
ROE -82.56%
ROIC N/A
ROA(3y)-40.11%
ROA(5y)-33.2%
ROE(3y)-83.38%
ROE(5y)-70.74%
ROIC(3y)N/A
ROIC(5y)N/A
REAX Yearly ROA, ROE, ROICREAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

Looking at the Gross Margin, with a value of 9.07%, REAX is doing worse than 65.63% of the companies in the same industry.
In the last couple of years the Gross Margin of REAX has declined.
REAX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y-6.44%
REAX Yearly Profit, Operating, Gross MarginsREAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

7

2. Health

2.1 Basic Checks

REAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
REAX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for REAX has been increased compared to 5 years ago.
There is no outstanding debt for REAX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
REAX Yearly Shares OutstandingREAX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
REAX Yearly Total Debt VS Total AssetsREAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 22.24 indicates that REAX is not in any danger for bankruptcy at the moment.
REAX has a better Altman-Z score (22.24) than 96.88% of its industry peers.
REAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 22.24
ROIC/WACCN/A
WACC9.05%
REAX Yearly LT Debt VS Equity VS FCFREAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.34 indicates that REAX should not have too much problems paying its short term obligations.
REAX has a Current ratio (1.34) which is in line with its industry peers.
REAX has a Quick Ratio of 1.34. This is a normal value and indicates that REAX is financially healthy and should not expect problems in meeting its short term obligations.
REAX has a Quick ratio (1.34) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.34
REAX Yearly Current Assets VS Current LiabilitesREAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

REAX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.67%.
The Revenue has grown by 83.53% in the past year. This is a very strong growth!
The Revenue has been growing by 140.25% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)6.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
Revenue 1Y (TTM)83.53%
Revenue growth 3Y118.22%
Revenue growth 5Y140.25%
Sales Q2Q%93.35%

3.2 Future

Based on estimates for the next years, REAX will show a very strong growth in Earnings Per Share. The EPS will grow by 38.82% on average per year.
The Revenue is expected to grow by 29.21% on average over the next years. This is a very strong growth
EPS Next Y49%
EPS Next 2Y38.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year41.52%
Revenue Next 2Y29.21%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
REAX Yearly Revenue VS EstimatesREAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
REAX Yearly EPS VS EstimatesREAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.05 -0.1 -0.15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for REAX. In the last year negative earnings were reported.
Also next year REAX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
REAX Price Earnings VS Forward Price EarningsREAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, REAX is valued cheaply inside the industry as 81.25% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 19.09
EV/EBITDA N/A
REAX Per share dataREAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as REAX's earnings are expected to grow with 38.82% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.82%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

REAX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REAL BROKERAGE INC/THE

NASDAQ:REAX (4/22/2025, 8:00:01 PM)

After market: 4.5 -0.16 (-3.43%)

4.66

+0.22 (+4.95%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-06 2025-03-06/bmo
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners45.44%
Inst Owner Change0.09%
Ins Owners13.08%
Ins Owner ChangeN/A
Market Cap910.56M
Analysts86
Price Target6.8 (45.92%)
Short Float %1.84%
Short Ratio3.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)50.98%
Min EPS beat(2)34.64%
Max EPS beat(2)67.32%
EPS beat(4)3
Avg EPS beat(4)12.33%
Min EPS beat(4)-103.64%
Max EPS beat(4)67.32%
EPS beat(8)5
Avg EPS beat(8)0.27%
EPS beat(12)7
Avg EPS beat(12)-0.53%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.92%
Min Revenue beat(2)5.3%
Max Revenue beat(2)14.54%
Revenue beat(4)4
Avg Revenue beat(4)16.32%
Min Revenue beat(4)5.3%
Max Revenue beat(4)26.33%
Revenue beat(8)8
Avg Revenue beat(8)18.08%
Revenue beat(12)12
Avg Revenue beat(12)21.58%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.25%
EPS NY rev (1m)0%
EPS NY rev (3m)12.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)11.36%
Revenue NY rev (1m)9.16%
Revenue NY rev (3m)8.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.72
P/FCF 19.09
P/OCF 18.69
P/B 28.33
P/tB 44.25
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)0.24
FCFY5.24%
OCF(TTM)0.25
OCFY5.35%
SpS6.47
BVpS0.16
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.65%
ROE -82.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.07%
FCFM 3.77%
ROA(3y)-40.11%
ROA(5y)-33.2%
ROE(3y)-83.38%
ROE(5y)-70.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y-6.44%
F-Score6
Asset Turnover14.6
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 74.86%
Cap/Sales 0.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.34
Altman-Z 22.24
F-Score6
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)185.96%
Cap/Depr(5y)132.21%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
EPS Next Y49%
EPS Next 2Y38.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)83.53%
Revenue growth 3Y118.22%
Revenue growth 5Y140.25%
Sales Q2Q%93.35%
Revenue Next Year41.52%
Revenue Next 2Y29.21%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year293.36%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y147.8%
FCF growth 3Y133%
FCF growth 5YN/A
OCF growth 1Y145.21%
OCF growth 3Y131.26%
OCF growth 5YN/A